KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Teva Pharmaceutical Industries (TEVA) Short term Debt (2016 - 2026)

Teva Pharmaceutical Industries filings provide 18 years of Short term Debt readings, the most recent being $2.6 billion for Q1 2026.

  • On a quarterly basis, Short term Debt rose 520.43% to $2.6 billion in Q1 2026 year-over-year; TTM through Mar 2026 was $2.6 billion, a 520.43% increase, with the full-year FY2025 number at $1.8 billion, up 2.19% from a year prior.
  • Short term Debt hit $2.6 billion in Q1 2026 for Teva Pharmaceutical Industries, up from $1.8 billion in the prior quarter.
  • In the past five years, Short term Debt ranged from a high of $3.1 billion in Q1 2024 to a low of $24.0 million in Q3 2025.
  • Median Short term Debt over the past 5 years was $1.8 billion (2025), compared with a mean of $1.7 billion.
  • Biggest five-year swings in Short term Debt: plummeted 99.07% in 2025 and later surged 520.43% in 2026.
  • Teva Pharmaceutical Industries' Short term Debt stood at $2.1 billion in 2022, then dropped by 20.72% to $1.7 billion in 2023, then rose by 6.52% to $1.8 billion in 2024, then grew by 2.19% to $1.8 billion in 2025, then surged by 43.52% to $2.6 billion in 2026.
  • The last three reported values for Short term Debt were $2.6 billion (Q1 2026), $1.8 billion (Q4 2025), and $24.0 million (Q3 2025) per Business Quant data.